Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fintech World Post.
Press releases published on May 13, 2025
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025
GlobeNewswire
·
May 13, 2025
GARDEN CITY, NY, May 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, announced today that they will be presenting first quarter 2025 financial …
Landstar System Reports First Quarter Revenue of $1.153B and Earnings per Share of $0.85 and Announces 11% Increase to Quarterly Dividend
GlobeNewswire
·
May 13, 2025
JACKSONVILLE, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Landstar System, Inc. (NASDAQ: LSTR) (“Landstar” or the “Company”) today reported basic and diluted earnings per share (“EPS”) of $0.85 in the 2025 first quarter on revenue of $1.153 billion. “The …
Consumer expert Lady Janey claims businesses could lose out with overreliance on AI in customer service
GlobeNewswire
·
May 13, 2025
TEWKESBURY, United Kingdom, May 13, 2025 (GLOBE NEWSWIRE) -- A consumer expert has said businesses must put customers at the forefront of any plans to expand the use of AI - or risk losing trade. Jane Hawkes, from the Lady Janey blog, said UK brands “risk …
Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment
GlobeNewswire
·
May 13, 2025
Raanana, Israel, May 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, recently announced the initiation of …
Intuitive Machines Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 13, 2025
HOUSTON, May 13, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology and infrastructure services company, today announced its financial results for the first quarter ended …
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
GlobeNewswire
·
May 13, 2025
Progress continues in Phase 3 Orbit study of setrusumab in osteogenesis imperfecta (OI) Cash of $62.5 million as of March 31, 2025, expected to fund operations into 2027 LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“ …
Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 13, 2025
Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting Enrollment ongoing in FORTIFI-HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC Strong financial position with approximately $462 …
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire
·
May 13, 2025
Achieved record quarterly sales of $11.5 million in Q1 2025, an increase of 27% compared to Q1 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.3 million, increasing by 519% and 81%, respectively, compared to Q1 of 2024 Shipped a …
ManageMy Secures ReMark’s Direct Marketing Business to Enhance Insurance Customer Engagement and Lifetime Value
GlobeNewswire
·
May 13, 2025
CHARLOTTE, N.C., May 13, 2025 (GLOBE NEWSWIRE) -- ManageMy, the SaaS provider simplifying digital experiences for carriers, customers, and agents, is proud to announce the strategic integration of ReMark’s direct marketing business following its December …
Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update
GlobeNewswire
·
May 13, 2025
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative …
Caliber Hospitality Development Launches to Pursue Opportunistic and Distressed Hotel Investments
GlobeNewswire
·
May 13, 2025
SCOTTSDALE, Ariz., May 13, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced the launch of Caliber Hospitality Development, LLC (“CHD”), a joint venture between Caliber and GIA Hospitality, LLC …
FAVO Capital Announces Conversion of Super Voting Series C Shares to Common Stock
GlobeNewswire
·
May 13, 2025
FORT LAUDERDALE, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- FAVO Capital, Inc. (OTC: FAVO), a publicly traded private credit firm specializing in merchant cash advances (MCAs) and revenue-based financing for underserved small and medium-sized …
First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
GlobeNewswire
·
May 13, 2025
- ATTRibute-CM, BridgeBio’s Phase 3 clinical trial of acoramidis in patients with ATTR-CM, achieved statistical significance in reducing the risk of ACM or first CVH versus placebo in ATTRv-CM patients (59.1% risk reduction), establishing the mechanistic …
UNISYNC Reports Q2 Fiscal 2025 Operating Results Showing Continued Improvement in Profitability
GlobeNewswire
·
May 13, 2025
TORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- Unisync Corp. (“Unisync”) (TSX:"UNI") (OTC:“USYNF”) is pleased to report a net income before tax of $1.0 million($0.05/share) and an Adjusted EBITDA of $3.1 million($0.16/share) on revenues of $24.5 million for the …
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
GlobeNewswire
·
May 13, 2025
Filed 510(k)Submission with FDA for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule Company Fully Funded Through at Least Fiscal Year 2026 Following Oversubscribed $8.2 Million Capital Raise EDEN PRAIRIE, Minn., May 13, 2025 …
Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 13, 2025
- Commenced market launch and first commercial sales of Symvess™ (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma - - Total revenues of $517,000 for quarter from sales and collaborative research agreement – - …
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program
GlobeNewswire
·
May 13, 2025
Reiterates Planned Submission of an NDA for Cytisinicline to FDA in June 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. …
Nayax Reports First Quarter 2025 Results
GlobeNewswire
·
May 13, 2025
Expands global customer base to more than 100,000 Total revenue of $81.1 million, recurring revenue growth of 35% YoY Gross Margin grew significantly to 49% Net income of $7.2 million with Adjusted EBITDA of $9.7 million (1) Company reaffirms full year …
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
GlobeNewswire
·
May 13, 2025
Pipeline advancements: The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review by the European Marketing Authority (EMA) and Takeda initiated its Phase 3 trial exploring mezagitamab for …
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 13, 2025
BURLINGTON, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business updates …